-
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.
Breccia M,
Latagliata R,
Carmosino I,
Cannella L,
Diverio D,
Guarini A,
De Propris MS,
Petti MC,
Avvisati G,
Cimino G,
Mandelli F,
Lo-Coco F.
PMID: 18945746 [PubMed - indexed for MEDLINE]
-
Patient Drug Information
-
Daunorubicin (Cerubidine® , DaunoXome® )
Your doctor has ordered the drug daunorubicin to help treat your illness. The drug is given by injection into a vein.
-
Tretinoin (Vesanoid® )
Tretinoin is used to treat acute promyelocytic leukemia (APL; a type of cancer in which there are too many immature blood cells in the blood and bone marrow) in people who have not been helped by other types of chemother...
-
Idarubicin (Idamycin PFS® )
Your doctor has ordered the drug idarubicin to help treat your illness. The drug is given by injection into a vein.